NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
NovoCure(NVCR) stock is priced at $14.41, giving the company a market capitalization of 1.68B. It carries a P/E multiple of -10.57.
On 2026-10-15, NovoCure(NVCR) stock traded between a low of $13.84 and a high of $14.46. Shares are currently priced at $14.41, which is +4.2% above the low and -0.3% below the high.
NovoCure(NVCR) shares are trading with a volume of 1.35M, against a daily average of 1.67M.
During the past year, NovoCure(NVCR) stock moved between $9.82 at its lowest and $21.45 at its peak.
During the past year, NovoCure(NVCR) stock moved between $9.82 at its lowest and $21.45 at its peak.
NVCR News
NovoCure (NVCR) just cleared a meaningful regulatory hurdle in Japan, with the country’s health ministry approving Optune Pax for unresectable locally advanced...
Japan’s Ministry of Health, Labour and Welfare has approved NovoCure’s Optune Pax device for adults with unresectable locally advanced pancreatic cancer, used t...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.